MoneyWorks4Me

Biocon informs about company statement

12 Feb 2021 Evaluate
Biocon has informed that it has submitted company statement titled ‘Biocon Biologics and Viatris Receive European Commission Approval for Kixelle, Biosimilar Insulin Aspart’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..